Our Pricing

Comparing Weight Loss Progress On Mounjaro 5mg Options

Understanding mounjaro 5mg weight loss progress UK benchmarks helps you evaluate whether your treatment is on track. At Cured Pharmacy, our UK-registered clinical team supports patients through every stage of tirzepatide therapy, from initial 2.5mg titration through maintenance dosing, with transparent pricing from £135.00 and discreet delivery across the UK.

What to Expect During Mounjaro 5mg Weight Loss Progress

Mounjaro 5mg represents the second maintenance dose in the tirzepatide titration schedule, typically reached after four weeks on the 2.5mg starter dose [1]. Clinical trial data from the SURMOUNT-1 study showed that patients on 5mg tirzepatide achieved an average body weight reduction of 15.0% over 72 weeks, compared to 3.1% with placebo [1]. However, individual mounjaro 5mg weight loss progress varies significantly based on baseline weight, adherence to lifestyle modifications, and metabolic factors.

During the first month on 5mg, most patients experience gradual appetite suppression and improved satiety after smaller meals. Weight loss typically accelerates between weeks 8 and 20 as the medication reaches steady-state plasma concentrations [2]. UK prescribers at Cured Pharmacy monitor progress through regular check-ins, adjusting the treatment plan if weight loss plateaus or side effects become problematic.

It's important to recognise that 5mg is not the final dose for many patients. The licensed Mounjaro titration schedule allows escalation to 7.5mg, 10mg, 12.5mg, or 15mg at four-week intervals, subject to prescriber approval and tolerability [1]. Patients who achieve less than 5% body weight reduction after 12 weeks on a given dose may benefit from dose escalation, though this decision must be made by a UK-registered prescriber following clinical assessment.

Mounjaro 5mg vs Higher Doses: Clinical Evidence

The SURMOUNT-1 trial directly compared tirzepatide doses across 2,539 adults with obesity, providing robust evidence for dose-response relationships [1]. At 72 weeks, the 5mg dose produced 15.0% average weight reduction, whilst the 10mg dose achieved 19.5%, and the 15mg dose reached 20.9% [1]. These results demonstrate that higher doses deliver incrementally greater weight loss, though individual response varies considerably.

Importantly, the rate of weight loss differs across doses. Patients on 15mg typically reach their maximum weight reduction faster than those on 5mg, with steeper decline curves in the first 36 weeks [2]. However, higher doses also carry increased risk of gastrointestinal side effects, including nausea, diarrhoea, and vomiting, which led to treatment discontinuation in 6.2% of participants on 15mg versus 2.6% on 5mg [1].

UK prescribers balance efficacy against tolerability when determining optimal dosing. At Cured Pharmacy, our clinical team evaluates your mounjaro 5mg weight loss progress at regular intervals, considering factors such as percentage body weight lost, side effect profile, and proximity to your target weight. Dose escalation is appropriate when weight loss stalls and side effects remain manageable, whilst dose maintenance or reduction may be recommended if you're experiencing significant adverse effects or approaching your goal weight.

When to Consider Dose Escalation

NICE guidance suggests that weight loss medications should produce at least 5% body weight reduction within 12 weeks to justify continuation [3]. If you've been on Mounjaro 5mg for three months without reaching this threshold, your UK prescriber may recommend escalation to 7.5mg or 10mg, subject to clinical assessment. Conversely, patients who achieve satisfactory progress on 5mg may remain on this maintenance dose long-term, particularly if higher doses cause intolerable side effects.

Comparing Mounjaro 5mg Progress With Alternative GLP-1 Treatments

Understanding how Mounjaro 5mg compares to other UK-licensed weight loss medications helps contextualise your progress. Wegovy (semaglutide) at its maintenance dose of 2.4mg weekly produced 14.9% average weight reduction over 68 weeks in the STEP 1 trial — remarkably similar to Mounjaro 5mg outcomes [4]. However, Mounjaro's dual GIP/GLP-1 mechanism may offer advantages in glycaemic control and lipid profiles, even at lower doses [2].

Saxenda (liraglutide), a daily injectable GLP-1 agonist, achieved 8.0% average weight loss over 56 weeks at its maximum 3.0mg dose [5]. This lower efficacy reflects both the different molecular structure and daily versus weekly dosing schedule. Patients who struggle with daily injections often find better adherence with once-weekly Mounjaro, which can improve long-term mounjaro 5mg weight loss progress outcomes.

At Cured Pharmacy, we stock the full range of UK-licensed weight loss treatments, allowing our prescribers to tailor recommendations to your individual circumstances. Transparent upfront pricing from £135.00 for Mounjaro means you can compare costs before completing your free online consultation, which typically takes under three minutes.

Switching Between Weight Loss Medications

Some patients begin with one GLP-1 treatment and switch to another due to supply issues, side effects, or inadequate response. Switching from Wegovy to Mounjaro, or vice versa, requires careful dose equivalence consideration by your UK prescriber. Generally, patients established on Wegovy 2.4mg may transition to Mounjaro 5mg or 7.5mg, though individual titration plans vary. All switches must be supervised by a registered prescriber to minimise adverse effects and maintain treatment efficacy.

Factors That Influence Mounjaro 5mg Weight Loss Progress

Medication alone does not determine outcomes. Clinical trials required participants to follow reduced-calorie diets and increase physical activity, conditions that significantly enhance tirzepatide's effects [1]. Patients who maintain a 500-calorie daily deficit alongside Mounjaro 5mg typically achieve faster and more substantial weight loss than those who rely on medication alone.

Baseline body mass index also affects response rates. Individuals with BMI over 40 kg/m² often experience larger absolute weight reductions but may require higher doses to achieve the same percentage loss as those with BMI 30-35 kg/m² [2]. Sleep quality, stress levels, and underlying metabolic conditions such as polycystic ovary syndrome or hypothyroidism can further modulate treatment response, which is why comprehensive clinical assessment is essential before starting any weight loss medication.

Adherence to the weekly injection schedule is critical. Missing doses or inconsistent timing can disrupt steady-state drug levels, reducing efficacy and potentially increasing side effects when you resume treatment. At Cured Pharmacy, we provide clear dosing instructions and support resources to help you maintain optimal adherence throughout your mounjaro 5mg weight loss progress journey.

Managing Side Effects While on Mounjaro 5mg

Gastrointestinal side effects are the most commonly reported adverse events with tirzepatide, affecting up to 80% of patients at some point during treatment [1]. Nausea, typically most pronounced in the first week after dose escalation, usually subsides within 3-5 days as your body adjusts. Eating smaller, more frequent meals and avoiding high-fat foods can minimise discomfort during this adjustment period.

Diarrhoea and constipation both occur in approximately 20-30% of patients on 5mg tirzepatide [1]. Maintaining adequate hydration and increasing dietary fibre intake helps regulate bowel function. If gastrointestinal symptoms persist beyond two weeks or significantly impact your quality of life, contact your UK prescriber to discuss dose adjustment or symptomatic management strategies.

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications. Mounjaro is contraindicated in individuals with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1]. Your Cured Pharmacy prescriber reviews your full medical history during the online consultation to ensure Mounjaro is safe and appropriate for you.

When to Seek Medical Advice

Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, signs of allergic reaction (rash, difficulty breathing, facial swelling), or symptoms of pancreatitis such as upper abdominal pain radiating to your back. These symptoms, whilst uncommon, require prompt medical evaluation. For non-urgent questions about your mounjaro 5mg weight loss progress or side effect management, our UK clinical team is available via phone on (+44) 116 4646009 during business hours.

Accessing Mounjaro 5mg Through Cured Pharmacy

Cured Pharmacy is a UK-registered online pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispense only genuine UK-licensed Mounjaro KwikPens, sourced directly from licensed wholesalers and stored in accordance with MHRA guidelines. Our transparent pricing from £135.00 includes the medication, clinical consultation, and discreet delivery to your UK address.

The consultation process takes under three minutes and involves a comprehensive medical questionnaire reviewed by a UK-registered prescriber. You'll receive a decision within hours during business days, and approved prescriptions are dispensed the same day for next-day delivery across most of the UK. All prescription medications, including Mounjaro, require clinical assessment by a UK prescriber before they can be legally supplied — there are no exceptions to this regulatory requirement.

We guarantee the lowest prices in the UK and offer 100% discreet packaging to protect your privacy. Unlike some online providers, Cured Pharmacy displays transparent upfront pricing before you begin your consultation, so you know exactly what you'll pay with no hidden fees. Our commitment to accessibility, affordability, and clinical excellence makes us the preferred choice for thousands of UK patients managing their mounjaro 5mg weight loss progress journey.

Next Steps to Start Treatment

Ready to begin or optimise your weight loss journey? Click 'Start Assessment' to complete your free online consultation with our UK clinical team. We'll review your medical history, current medications, and weight loss goals to determine whether Mounjaro 5mg or an alternative treatment is most appropriate for you. With same-day prescription processing and discreet next-day delivery, you could begin treatment as soon as tomorrow, subject to prescriber approval.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual weight loss results vary and depend on multiple factors including baseline weight, adherence to lifestyle modifications, and metabolic response. Clinical trial data represents average outcomes and may not reflect your individual experience.